Neurological Development in Very Low Birth Weight Infants with Congenital Heart Disease at 3 Years of Age: A Japanese

Yoshiki Mori1, Yasumi Nakashima2, Hiroshi Sugiura3

  • 1Division of Pediatric Cardiology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-Ku, Hamamatsu, Shizuoka, 430-8558, Japan. yoshikim57@gmail.com.

Pediatric Cardiology
|October 18, 2025
PubMed

Insights

Infants with congenital heart disease (CHD) and very low birth weight (VLBW) face higher risks of neurodevelopmental impairment. Serious CHD and extended hospital stays are key risk factors, necessitating early intervention and specialized care.

Area of Science:

  • Neonatology
  • Pediatric Cardiology
  • Developmental Pediatrics

Background:

  • Neurodevelopmental impairment is a growing concern in very low birth weight (VLBW) infants, especially those with congenital heart disease (CHD).
  • The prevalence and specific risk factors for neurodevelopmental issues in this population are not well-established.
  • Understanding these outcomes is crucial for timely intervention and improved long-term health.

Purpose of the Study:

  • To investigate neurodevelopmental outcomes in VLBW infants with and without CHD.
  • To identify independent risk factors associated with neurodevelopmental impairment in VLBW infants with CHD.

Main Methods:

  • A multicenter cohort study involving VLBW infants born between 2006 and 2014 without genetic or known anomalies.
  • Neurodevelopmental assessment at three years using the Kyoto Scale of Psychological Developmental (KSPD).
  • Poor neurodevelopment defined as a developmental quotient (DQ) < 70, cerebral palsy diagnosis, or clinical judgment.

Main Results:

  • Poor neurodevelopment outcomes were significantly more frequent in VLBW infants with CHD (36.5%) compared to those without (16.4%).
  • Infants with serious CHD showed particularly high rates of poor neurodevelopment (54.9%).
  • Serious CHD and prolonged hospitalization (> 13 weeks) were identified as independent risk factors.

Conclusions:

  • VLBW infants with CHD are at a substantially higher risk for neurodevelopmental impairment.
  • Early identification of risk factors, including serious CHD and prolonged hospitalization, is critical.
  • Multidisciplinary follow-up care is essential for this high-risk population.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...